Medical News

RSS

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that the first of two canine oncology products has received approval by regulators in both the U.S. and Canada.

24 Jul 2012

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.

24 Jul 2012

Recent release: Kaiser Health News interviews White House senior policy advisor ahead of AIDS 2012

In this Kaiser Health News interview, KHN contributor Joanne Silberner talks with Gregg Millett, senior policy adviser in the Office of National AIDS Policy, ahead of the XIX International AIDS Conference.

24 Jul 2012

Symposium to support care and management of women with HIV

International AIDS Conference, Washington D.C., USA: Women for Positive Action are holding an interactive satellite symposium at the AIDS 2012 Conference entitled Turning the tide in the care of women living with HIV, supporting the care and management of women living with HIV throughout their different life stages.

24 Jul 2012

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

The U.S. Food and Drug Administration today approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm (narrowing of the airways in the lung) associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

24 Jul 2012

Recent release: Kaiser Family Foundation/Washington Post poll shows positive news about public opinion and HIV

As the XIX International AIDS Conference convenes in Washington, D.C., Kaiser Family Foundation (KFF) President and CEO Drew Altman highlights positive news about public opinion and HIV from KFF's new survey of the American people conducted with the Washington Post in his latest "Pulling It Together" column.

24 Jul 2012

InnerSpace Neuro introduces new Tunneled Ventricular Catheter for TBI

InnerSpace Neuro, Inc., developer of the Hummingbird family of products used to treat Traumatic Brain Injury (TBI), today reported that an abstract featuring its Hummingbird SynergyDuo Ventricular Catheter is being presented at the Neurotrauma 2012 meeting in Phoenix, Arizona. The company also announced launch of its new Tunneled Ventricular Catheter.

23 Jul 2012

Working poor at heart of Medicaid expansion debate as governors draw line in the sand

Even as state executives such as Texas Gov. Rick Perry and Florida Gov. Rick Scott remain firm in their opposition to the health law's Medicaid expansion, health providers such as Cleveland Clinic CEO and President Tony Cosgrove express their support for it.

23 Jul 2012

Neural precursor cells suppress aggressive tumors

Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors.

23 Jul 2012

Synthetic triterpenoids block development of Parkinson's disease

A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.

23 Jul 2012

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.

23 Jul 2012

Tiny microneedles to treat macular degeneration

Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.

23 Jul 2012

Third-party groups to target health law with new wave of attack ads

Also in the news, the Supreme Court -- especially after the recent health law decision -- is an effective tool to rally fundraising among both Democrats and Republicans. Meanwhile, a defense policy expert suggests presidential candidates focus on long-term military mental health issues. Finally, The Wall Street Journal examines how health care is playing in the Montana Senate race, where candidates are sparring over who is soft on cancer.

23 Jul 2012

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

HALO Healthcare, Inc., a provider of innovative diagnostic solutions for women's breast care announced that it has signed a definitive license agreement with the University of North Dakota (UND) to develop biomarkers for the early detection of breast cancer.

23 Jul 2012

Once-daily Gralise significantly reduces pain intensity in PHN patients

Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).

23 Jul 2012

New investment to fund Chiasma's Octreolin Phase 3 pivotal program for acromegaly

Chiasma, Inc., a privately held biopharma company, announced that it closed a $38.5 million equity financing co-led by new investor Abingworth and current investor MPM Capital that also included investments from existing shareholders 7 Med Health Ventures, ARCH Venture Partners, F3 Ventures and Fredric Price, Chiasma's Chairman & CEO.

23 Jul 2012

Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia

Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."

23 Jul 2012

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.

23 Jul 2012

Overeating and increased weight linked to brain region associated with motivation and reward

Snack consumption and BMI are linked to both brain activity and self-control, new research has found.

23 Jul 2012

URAC awards Health Utilization Management Accreditation to MagnaCare

MagnaCare, a healthcare services company, today announced that it has earned Health Utilization Management Accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

23 Jul 2012

Medical News

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Recent release: Kaiser Health News interviews White House senior policy advisor ahead of AIDS 2012

Symposium to support care and management of women with HIV

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

Recent release: Kaiser Family Foundation/Washington Post poll shows positive news about public opinion and HIV

InnerSpace Neuro introduces new Tunneled Ventricular Catheter for TBI

Working poor at heart of Medicaid expansion debate as governors draw line in the sand

Neural precursor cells suppress aggressive tumors

Synthetic triterpenoids block development of Parkinson's disease

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

Tiny microneedles to treat macular degeneration

Third-party groups to target health law with new wave of attack ads

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

Once-daily Gralise significantly reduces pain intensity in PHN patients

New investment to fund Chiasma's Octreolin Phase 3 pivotal program for acromegaly

Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Overeating and increased weight linked to brain region associated with motivation and reward

URAC awards Health Utilization Management Accreditation to MagnaCare

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News